scholarly journals Prevalence of Long-term Post COVID-19 Symptom and Blood Group Correlation

2021 ◽  
Vol 13 (4) ◽  
pp. 400-404
Author(s):  
Nuzhat Banu ◽  
Aljawhara Abdullah Algosaibi ◽  
Khaton Abdullah Alhazza ◽  
Layla Makki Al Janbi ◽  
Mohammad Daud Ali ◽  
...  
Keyword(s):  
Blood Group

ABO histo-blood group antigen expression on the graft endothelium long term after ABO-compatible, non-identical heart transplantation.

2006 ◽  
Vol 13 (2) ◽  
pp. 166-170 ◽  
Author(s):  
Simon C. Koestner ◽  
Andreas Kappeler ◽  
Thomas Schaffner ◽  
Thierry P. Carrel ◽  
Paul J. Mohacsi
Keyword(s):  
Heart Transplantation ◽  
Blood Group ◽  
Antigen Expression ◽  
Blood Group Antigen

scholarly journals Long-Term Balancing Selection at the Blood Group-Related Gene B4galnt2 in the Genus Mus (Rodentia; Muridae)

2011 ◽  
Vol 28 (11) ◽  
pp. 2999-3003 ◽  
Author(s):  
Miriam Linnenbrink ◽  
Jill M. Johnsen ◽  
Inka Montero ◽  
Christine R. Brzezinski ◽  
Bettina Harr ◽  
...  
Keyword(s):  
Blood Group ◽  
Balancing Selection ◽  
Related Gene

Response to Anti D immunoglobulin in Adults with Chronic Immune Thrombocytopenic Purpura in a Minority Cohort with Long Term Follow up.

Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 4465-4465
Author(s):  
Shylendra B Sreenivasappa ◽  
Tareq Braik ◽  
Sonia Sandhu ◽  
Barbara Yim ◽  
Rosalind Catchatourian
Keyword(s):  
Blood Group ◽  
Immune Thrombocytopenic Purpura ◽  
Univariate Analysis ◽  
Poor Response ◽  
Complete Response ◽  
Median Number ◽  
Time To Progression ◽  
Thrombocytopenic Purpura ◽  
Time To Relapse

Abstract Abstract 4465 Background Immune Thrombocytopenic Purpura (ITP) is a common hematological disorder. We sort to characterize the risk profiles and efficacy of anti D immunoglobulin in chronic ITP in a largely minority cohort. Methods 31 patients (pts) with chronic immune thrombocytopenic purpura treated 2003-2008 were studied as a retrospective cohort for clinical presentation, prognostic characteristics, time to next therapy and long term survival. Prognostic factors, time to relapse and overall survival was analyzed using fisher's exact test, logistic regression, Kaplan Meier survival analysis and Cox Proportional Hazards model. Results 31 pts 19(61.3%) female and 12(38.7%) male. 11 (35.5%) African Americans, 12(38.7%) Hispanic, 5 (16.2%) Asians and 3 (7.8%) Caucasians. Median age at diagnosis was 44 yrs (21-66). 25 (80.5%) were HIV negative and 6 (19.5%) had HIV. 16 (51.6%) had O positive blood group, 9 (29.6%) had A positive and 4 (12.9%) had B positive. The median number of co-morbidities at diagnosis was 1(0-6). Median age at which anti D immunoglobulin was initiated was 45 yrs. Pt had received a median of 3 (2-6) therapies prior to anti D therapy. All patients had received steroids, 17 (54.8%) had immunoglobulin therapy, 2 (6.5%) had vincristine and 6(19.3%) had splenectomy prior to anti D therapy. The median duration to anti D therapy was 6 months (0-228). Anti D therapy was given in the dose of 50-75mcg/kg IV weekly. Median number of doses given was 2 (1-7) doses. The response rate was 64.5%. Response was defined as Complete response, platelet count of > 100 × 109/L, Partial response >30 × 109/L. 17 (54.8%) achieved complete response, 3 (9.7%) achieved partial response. 11(35.5%) did not respond. Median time to relapse was 4 months (0-79). 9 (29%) achieved a complete response for over a year. Pt with HIV (p=0.013), O blood group (p=0.030) had a significant poor response to anti D therapy on univariate analysis. Pt with HIV (p=0.035) had poor response to therapy on multivariate analysis. O blood group (p=0.001), HIV (p=0.016), > 2 lines of therapy (p=0.007), one dose of anti D (0.037) were associated with shorter time to progression on univariate analysis. On multivariate analysis prior immunoglobulin administration (p=0.039), >2 lines of therapy (p=0.004) and single dose of anti D immunoglobulin (p=0.039) were associated with shorter time to progression. Conclusion Anti D immunoglobulin had a response rate of 64.5% which is similar to other studies. About 29% of patients had a complete response for over a year. Pts who not received anti D immunoglobulin, HIV negative and early anti D administration had the best response and longer time to progression. Disclosures: No relevant conflicts of interest to declare.

Improving Access to Kidney Transplantation without Decreasing Graft Survival: Long-Term Outcomes of Blood Group A2/A2B Deceased Donor Kidneys in B Recipients

2005 ◽  
Vol 80 (1) ◽  
pp. 75-80 ◽  
Author(s):  
Christopher F. Bryan ◽  
Franz T. Winklhofer ◽  
Daniel Murillo ◽  
Gilbert Ross ◽  
Paul W. Nelson ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Graft Survival ◽  
Blood Group ◽  
Deceased Donor ◽  
Long Term Outcomes

scholarly journals Can Our Blood Groups Determine Our Life Expectancy?

2021 ◽  
Author(s):  
Gülçin Şahingöz Erdal ◽  
İsmail Bıyık ◽  
Pınar Kasapoğlu ◽  
Muhammet Hulusi Satılmışoğlu ◽  
Nlgün Işıksaçan
Keyword(s):  
Acute Coronary Syndrome ◽  
Blood Group ◽  
Blood Groups ◽  
Term Survival ◽  
Coronary Syndrome ◽  
Study Results ◽  
Significant Difference ◽  
Balanced Distribution ◽  
Tertiary Hospitals

Background/aim: In this study, we aimed to investigate the relationship between long-term mortality and survival with ABO blood group in patients with acute coronary syndrome. Materials and methods: This observational study was carried out in two tertiary hospitals. 192 patients followed for 72 months due to acute coronary syndrome, showing a balanced distribution for ejection fraction, additional diseases and age, were included in the study. Results: The survival rate was evaluated in 72 months follow-up. In the survival analysis according to individual blood groups; there was no statistically significant difference between the groups. When the patients were divided into two groups, there was 24.39% mortality in those with O blood group and 15.23% mortality in those without O blood group (p>0.05). Although it was not statistically significant, in patients with O blood group, an increasing tendency was observed in 72 month mortality (p>0.05). There was no association between Rh antigen and survival in this study (p=0.79). Conclusion: Although it was not able to reach statistically significance limit, a decreasing tendency in long-term survival was observed in patients with O blood group compared to those without O blood group in patients with acute coronary syndrome. The results should be confirmed by larger prospective studies.

AB0-incompatible pediatric heart transplantation - long-term induced tolerance against donor blood group

2014 ◽  
Vol 62 (S 02) ◽  
Author(s):  
S. Ulrich ◽  
A. Lehner ◽  
R. Engmann ◽  
L. Hakami ◽  
C. Hagl ◽  
...  
Keyword(s):  
Heart Transplantation ◽  
Blood Group ◽  
Donor Blood ◽  
Pediatric Heart Transplantation ◽  
Induced Tolerance

scholarly journals Intragraft expression of recipient-type ABO blood group antigens: Long-term follow-up and histological features after liver transplantation

2005 ◽  
Vol 11 (5) ◽  
pp. 547-554 ◽  
Author(s):  
Yuichi Tanaka ◽  
Hironori Haga ◽  
Hiroto Egawa ◽  
Tomoko Okuno ◽  
Aya Miyagawa-Hayashino ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Blood Group ◽  
Abo Blood Group ◽  
Blood Group Antigens ◽  
Histological Features ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document